Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Inhalation Anesthesia Market: By Product Type, By Application Type and Region Forecast 2021-2032
Inhalation Anesthesia Market: By Product Type, By Application Type and Region Forecast 2021-2032
Report ID:64055
Published Date:Nov 2025
No of Pages:226
Format:
Inhalation Anesthesia Market size was valued at US$ 1.6 billion in 2025 and is expected to reach US$ 2.2 billion by 2032, growing at a significant CAGR of 4.9% from 2026-2032. The rapid increase in the aging population with cancer, cardiovascular, spinal, orthopedic, respiratory, gastrointestinal, and other diseases and disorders is expected to drive the growth of the market. According to the WHO, cancer is one of the world's leading causes of morbidity and mortality, with nearly 18 million cases in 2019 alone, and is predicted to grow by around 70% over the next 20 years. Meanwhile, growing concern about the role of greenhouse gases such as sevoflurane, isoflurane, and desflurane in climate change could impede market growth.
The Sevoflurane segment accounted for a share of sales of more than 70% in 2020 and the segment of induction was valued at about US$ 250 million in 2019 and will expect similar trends in growth over the coming years. This study analyses the global market dynamics in a detailed manner to identify current trends and drivers, growth opportunities, and potential challenges to the key stakeholders in the operating market.
Study Period
2026-2032Base Year
2025CAGR
4.9%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Owing to the rise in number of surgeries being conducted, the market is projected to expand globally. The rapid increase in ageing population with cancer, respiratory, gastrointestinal, neurological diseases and disorders are expected to drive the growth of the market. The increasing number of orthopedic procedures also contributes to the growth of day care outpatient surgery, which is expected to boost the use of inhalation anesthesia. In addition, a growing number of emergency cases and accidents are also expected to have a positive effect on market growth over the forecast period.
The increasing prevalence of chronic diseases resulting from unhealthy dietary habits and lifestyle changes will increase business growth. In 2019, the Asia Pacific market had been estimated at USD 297 million. Primary factors contributing to the rapid growth of the market include increased population, public and private healthcare, availability of healthcare insurance, and prevalence of chronic disease.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2026-2032 |
|
Market CAGR |
4.9% |
|
By Product Type |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
The inhalation anesthesia market size was valued at US$ 1.6 billion in 2025 and is expected to reach US$ 2.2 billion by 2032, growing at a significant CAGR of 4.9% from 2026-2032
Halocarbon products corporation, Hikima Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd., Piramal Enterprises Limited, Jiangsu Hengrui Medicine Co. Ltd., Fresenius Kabi AG, AbbVie Inc., Baxter
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Content Updated Date: Mar 2026
| 1.Executive Summary |
| 2.Global Inhalation Anesthesia Market Introduction |
| 2.1.Global Inhalation Anesthesia Market - Taxonomy |
| 2.2.Global Inhalation Anesthesia Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.Region |
| 3.Global Inhalation Anesthesia Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Inhalation Anesthesia Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 |
| 4.1. Market Analysis, 2021 - 2025 and Forecast, 2026 - 2032, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Inhalation Anesthesia Market By Product Type, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 5.1. Sevoflurane |
| 5.1.1. Market Analysis, 2021 - 2025 and Forecast, 2026 - 2032, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Isoflurane |
| 5.2.1. Market Analysis, 2021 - 2025 and Forecast, 2026 - 2032, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Desflurane |
| 5.3.1. Market Analysis, 2021 - 2025 and Forecast, 2026 - 2032, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Inhalation Anesthesia Market By Application, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 6.1. Induction |
| 6.1.1. Market Analysis, 2021 - 2025 and Forecast, 2026 - 2032, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Maintenance |
| 6.2.1. Market Analysis, 2021 - 2025 and Forecast, 2026 - 2032, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Inhalation Anesthesia Market By Region, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2021 - 2025 and Forecast, 2026 - 2032, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2021 - 2025 and Forecast, 2026 - 2032, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2021 - 2025 and Forecast, 2026 - 2032, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2021 - 2025 and Forecast, 2026 - 2032, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2021 - 2025 and Forecast, 2026 - 2032, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Inhalation Anesthesia Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Sevoflurane |
| 8.1.2.Isoflurane |
| 8.1.3.Desflurane |
| 8.2. Application Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Induction |
| 8.2.2.Maintenance |
| 8.3. Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Inhalation Anesthesia Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Sevoflurane |
| 9.1.2.Isoflurane |
| 9.1.3.Desflurane |
| 9.2. Application Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Induction |
| 9.2.2.Maintenance |
| 9.3. Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Inhalation Anesthesia Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Sevoflurane |
| 10.1.2.Isoflurane |
| 10.1.3.Desflurane |
| 10.2. Application Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Induction |
| 10.2.2.Maintenance |
| 10.3. Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Inhalation Anesthesia Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Sevoflurane |
| 11.1.2.Isoflurane |
| 11.1.3.Desflurane |
| 11.2. Application Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Induction |
| 11.2.2.Maintenance |
| 11.3. Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Inhalation Anesthesia Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Sevoflurane |
| 12.1.2.Isoflurane |
| 12.1.3.Desflurane |
| 12.2. Application Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Induction |
| 12.2.2.Maintenance |
| 12.3. Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Halocarbon products corporation |
| 13.2.2.AbbVie Inc. |
| 13.2.3.Baxter |
| 13.2.4.Hikima Pharmaceuticals PLC |
| 13.2.5.Lunan Pharmaceutical group Co. Ltd. |
| 13.2.6.Piramal Enterprises Limited |
| 13.2.7.Jiangsu Hengrui Medicine Co. Ltd. |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.